Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

320 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Strengths and weaknesses of the RAPID3 score.
Berthelot JM, Batard K, le Goff B, Maugars Y. Berthelot JM, et al. Joint Bone Spine. 2012 Dec;79(6):536-8. doi: 10.1016/j.jbspin.2012.03.005. Epub 2012 May 9. Joint Bone Spine. 2012. PMID: 22575066 No abstract available.
Clinical practice format for choosing a second-line disease modifying anti-rheumatic drug in early rheumatoid arthritis after failure of 6 months' first-line DMARD therapy.
Meyer O, de Bandt M, Berthelot JM, Cantagrel A, Combe B, Fautrel B, Flipo RM, Lioté F, Maillefert JF, Saraux A, Wendling D, Guillemin F, Le Loët X; Working Group for Therapeutic Strategies for Rheumatoid Arthritis. Meyer O, et al. Among authors: berthelot jm. Joint Bone Spine. 2007 Jan;74(1):73-8. doi: 10.1016/j.jbspin.2006.05.008. Epub 2006 Nov 29. Joint Bone Spine. 2007. PMID: 17194614
320 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page